Vedolizumab Induces Clinical Response and Remission Across a Range of Baseline Fecal Calprotectin Levels in Patients with Ulcerative Colitis: Results from GEMINI 1 Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Wyant, Tim
  • Lewis, James
  • Reinisch, Walter
  • Dassopoulos, Emistocles
  • Ginsburg, Philip
  • Sands, Bruce
  • Feagan, Brian
  • Danese, Silvio
  • Roseth, Arne
  • Rosario, Maria
  • Yang, Huyuan
  • Parikh, Asit
  • Bressler, Brian

publication date

  • October 1, 2014